Patent ID: 11873295
Assignee: PETRA PHARMA CORPORATION
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 46:
47. The compound of claim 46, or pharmaceutically acceptable salt thereof, wherein R1 is a group of the formula:, R2 is a group of the formula:, R3 is —H, —CN, or C1-C3 alkyl;
R4, and R are each —H;
R5 is —H, halogen, C1-C3 alkyl or C1-C3 haloalkyl;
R6 is —H or halogen;
R7 is —CN, methyl or trifluoromethyl;
each R9 is independently —H, halogen, methyl, or C1-C3 haloalkyl;
each R10 is independently —H, —CN, halogen, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, —SO2R11, —CONR11R11, —NR11R11, —NR11—CO2R11, an optionally substituted C1-C6 alkyl, an optionally substituted C3-C5 cycloalkyl, an optionally substituted heterocycle selected from pyrrolidine, pyrrolidinone, piperidine or morpholine, an optionally substituted phenyl, or an optionally substituted heteroaryl selected from pyrazole, isoxazole, isothiazole, imidazole, oxazole, or thiazole; wherein the optionally substituted C1-C6 alkyl is optionally substituted with a —CN, —OH, or C1-C3 alkoxy; the optionally substituted C3-C5 cycloalkyl, phenyl, heterocycle or heteroaryl is each optionally substituted with one to three substituents each independently selected from halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 haloalkoxy, —NR11R11, —OH or —CN; and
each R11 is independently —H or C1-C3 alkyl.